Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2014; 4(4): 001-007


Cytotoxicity assessment of aqueous extract from root barks of Calotropis procera (Ait.) R. Br. in human intestinal Caco-2 and mouse neuroblastoma Neuro-2a cell lines

Geoffroy G. OUEDRAOGO, Serge MOUKHA, Théophile A. MOBIO, Moustapha OUEDRAOGO, Pierre I. GUISSOU, Edmond E. CREPPY.




Abstract

Calotropis procera (Ait.) R. Br (Asclepiadaceae) is a species widely used in traditional medicine for the treatment of various diseases such as sickle cell disease, asthma and cancer. In Burkina Faso, it enter in the composition of FACA® in combination with Zanthoxylum zanthoxyloïdes Lam (Rutaceae), drug used in sickle cell disease treatment. The objective of this study was to evaluate the in vitro cytotoxicity of aqueous extract of root barks of the plant on cell lines to increase the safe use of FACA®. MTT and Neutral Red assays performed on Caco-2 and Neuro-2a cell lines revealed that aqueous extract from root barks of Calotropis procera are cytotoxic on these cell lines. DNA fragmentation assay on Caco-2 cell showed DNA smearing reflecting a degradation of nuclear material that indicates a possible genotoxicity. Altogether, it comes out that the most sensitive cell line is the human colorectal carcinoma Caco-2 cells. Comparatively the active compounds of Calotropis procera do not affect the mice nervous system cells in the same dramatic extent. Our results strongly suggest that patients under treatment of FACA® must respect doses prescribed in order to avoid adverse side effects on the gastrointestinal tract.

Key words: Calotropis procera Ait., cytotoxicity, FACA®, Caco-2 cell, Neuro-2a cell






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.